The Old Man’s Mouth

This edition will be a one-off and take a different lean to what I hope to talk about in future editions of the Monthly.

I. The Old Man’s Mouth

My grandmother loved to walk. Not the performative walking of people who have recently discovered wellness, but rather the quiet, purposeful movement of someone who simply needed to be outside. She lived in and around Scarborough her whole life, in the Wolds and in the wild as did her family before (and partly after). The sea was part of how she thought. She would walk along the front in all weathers, watching the North Sea do what the North Sea does: grey and particular and uncompromising.

One of the walks we did together, many times, was through Forge Valley. It’s a wooded gorge south of Scarborough, where the River Derwent runs narrow and clear under a canopy of oak and ash. In the spring, the onion flowers spread like fields, interrupted with speckled outcrops of primroses, and violets and forget-me-nots.

On autumn afternoons, when the fallen leaves had dammed the smaller channels feeding the river below, we would spend hours doing something that sounds peculiar when I describe it now: clearing the blockages from tiny tributaries. Not because anyone asked us to. But because we could see the water backing up, losing its path, spreading where, perhaps, it shouldn’t. And because there was a waterfall further down — the locals called it the Old Man’s Mouth — where the stream finally found the main river and cascaded over a small drop into the larger flow below. We were clearing the way for the water to get there, rather than onto the road below.

We walked many places together, through dale, dell and boggy glen — to the highest peaks of the Lake District, Helvellyn, Scafell Pike. There too, we cleared streams, shaping rocks not to dam the flow as many families and children harmlessly do in fun, but to hasten the water’s route to its intended destination.

My grandma was always in excellent health. Spritely is perhaps apt. (There is something in the genes that seem to compel the females in the family to walk at an incredible pace — whether it be to the local cornershop, or striding deep into the Yorkshire Dales.) Her grandmother (my great great grandma) had lived to 104 I’m told, and her mother too, 96. Our genetics — again, certainly on the female side of the family — suggested she had a long way left to go.

By any reasonable reckoning, she should still just about be here with us as I write this, if things had been slightly different. She could have seen my daughter grow into the person she is becoming. She should have been here for ten more years of her blossoming — the becoming, the questions, the small moments that accumulate into a life. My daughter’s life would have been richer for that. I know that without equivocation. My life was better for having her in it. I wish my daughter could have shared in my grandma’s wisdom, fun and love. I know my grandma worried about me as well. I had drifted after university.

She died of breast cancer. She had been to her GP a number of times, she knew something was wrong, and she kept going back, which tells you something about the kind of woman she was. The referral took a long time. The hospital appointment took longer. By the time the diagnosis came, it had metastasised. I do not say this to lay blame at any individual’s door. The people who saw her were doing their jobs within the constraints of the system they had. What failed her was not a person. It was the accumulated weight of delays — each one defensible in isolation, each one understandable when you know what NHS waiting times look like from the inside, but catastrophic in their sum.

She battled to stay in her own home. The idea of a hospital bed horrified her — she said, but because she knew what acute beds were for, and she didn’t want to take one from someone who needed it more. I went to visit her in hospital on occasion when she was admitted for a Talc procedure. Having worked in Respiratory Medicine before, I knew enough to understand what this was, but never really having first-hand understood its effects on patients, or fully appreciated why. She put on such a brave face, but I know she must have been scared, and in pain.

My mother moved in to care for her. Her son visited every day. I wrote to her. Letters and texts, from a distance that I sometimes wish had been shorter between Hull and Scarborough. She kept many of the messages I had sent jotted in her diary or in notes that were kept in her Holy Bible. I didn’t know that until after she died. I perhaps didn’t visit as often as I should have.

This editorial is named after that valley. Where my family have walked for generations. Not as a borrowed metaphor, not as a piece of emotional branding, but as an honest account of where one of the reasons for building the Value Forge came from.

She is the reason. My mum is the reason. My partner and my daughter. The Old Man’s Mouth is the reason.

It’s raining, it’s pouring, the old man is snoring — so the rhyme goes.

II. The Step Nobody Takes

Most people have a version of this story. A relative seen too late. A diagnosis that arrived when it could no longer change the outcome. A system that, in each of its individual parts, was functioning as designed — and yet, as a whole, did not do what it was supposed to do for the person standing in front of it.

This is not an argument for pessimism about the NHS. People who run it know that pessimism and optimism are both comfortable positions, and comfort is not what the system needs from those responsible for it. What it needs is something harder: the willingness to look at the gap between what good care looks like and what this system currently delivers, and to stay in that gap long enough to understand what is producing it.

The NHS has never had more information than it has now. Clinical guidance is produced and updated continuously. NICE publishes. NHS England publishes. Royal Colleges publish. Academic journals publish. Audit datasets accumulate. Dashboards are populated. Briefings circulate. Boards receive summary papers that reference evidence bases there has not been time to read. The epistemic problem of an earlier NHS — not knowing what good looked like — has been substantially addressed. The problem that replaced it is less frequently named.

Information is not knowledge.

Data tells you what happened. Information tells you what the data says when gathered, synthesised, and surfaced. Knowledge tells you what the information means — in context, for this patient, this population, this place, given everything else that is true about them. Wisdom is the judgment that applies that knowledge to a specific decision, in a specific moment, with full awareness of what cannot be known with certainty. The hierarchy is not academic. It is a description of what actually happens — or fails to happen — every time a clinician or manager has to translate a national recommendation into a specific action for a specific person.

The NHS produces enormous quantities of data. It processes much of it into information. The translation from information to knowledge — the step that requires context, population specificity, and the refusal to treat national averages as local truths — is the step that gets compressed under pressure. It is left to the individual in the room. It depends on their experience, their time, and their ability to hold multiple things at once while the next case is already waiting. The clinician who reads a guideline and mentally adjusts it against what they know about their patient list is doing this translation intuitively. The manager who reads a national improvement report and asks, “but what does that actually mean here?” is doing it. Everyone who has ever worked in a functioning clinical service is doing it, to some degree, every day.

The question is not whether the translation happens. It is whether it happens consistently, with enough depth and rigour and population specificity to change decisions in proportion to what the evidence would actually support. The honest answer, most of the time, is that it happens partially. Better than it would without it. Less well than the patients it serves deserve.

For specific populations — populations with higher deprivation, with greater clinical complexity, with patterns of need that diverge from national averages in ways that compound across pathways — the partial translation accumulates into a consistent gap. Between what good care looks like. And what patients actually receive.

III. This Population. This Place.

Hull carries some of the highest deprivation indices in England. The East Riding presents a different challenge — rurality, dispersed communities, distances that make access to care a material constraint rather than a logistical inconvenience. These are not contextual details. They are parameters that materially alter what good care looks like, how evidence applies, and what any given recommendation means when it meets a real patient in a real place.

Johannes Kepler had a problem. The received wisdom of his age — inherited from Aristotle, refined over centuries, accepted by every authority that mattered — held that the planets moved in perfect circles. Kepler was tasked with making the mathematics of planetary motion fit the observations of Tycho Brahe. He couldn’t. For years he tried. Eventually, he did something that required more intellectual courage than is easy to appreciate from this distance: he abandoned the inherited framework and looked at what the observations actually showed. The orbits were ellipses. The mathematics that followed changed the course of science.

The NHS relationship with national evidence guidance has something of the Aristotelian circle problem. The guidance is good — often excellent. The studies behind it are rigorous. The syntheses are carefully done. But they are built on populations that are not this population, in places that are not this place, under conditions that do not fully reflect what is true here. A meta-analysis on hospital at home has a sample. Hull is not proportionately in that sample. The guidance it produces is right in aggregate. It is incomplete as applied. The same is true across frailty, palliative care, psychology, therapies, and OPAT — five domains in which evidence is extensive, well-curated, and consistently synthesised at national level, and in which the translation to this specific population and these specific circumstances is left, almost entirely, to individual clinical judgment.

This is not a criticism of how evidence is produced. It is a structural feature of evidence production, and acknowledging it honestly is the first condition for doing anything useful about it. Nobody builds a clinical trial around the intersection of Hull’s deprivation profile and the East Riding’s rurality and the specific community capacity constraints that shape what is and is not deliverable here. Nobody runs a systematic review to answer the question: what does early supported discharge achieve for a frail older person living alone in a rural East Riding community with limited carer availability and a community nursing team that is at capacity? The answer is constructed, every time, from imperfect inference. It can be constructed better or worse. The Value Forge is an attempt to construct it better.

Five clinical domains, applied as a whole rather than in sequence. Acute frailty: comprehensive geriatric assessment, same-day emergency care, virtual wards, hospital at home, early supported discharge, the prevention of the deconditioning that turns a crisis into a permanent trajectory. Clinical psychology: the psychological need that sits invisible beside physical health conditions, under-identified and under-served, in acute and community settings across this patch. Palliative care: advance care planning that happens before the crisis rather than during it, preferred place of death honoured rather than overridden at two in the morning, the end of life managed with the dignity it requires. Therapies and allied health professions: rehabilitation intensity matched to rehabilitation potential, functional independence protected, the window between crisis and irreversible decline used rather than lost. Outpatient parenteral antimicrobial therapy: intravenous treatment delivered in community settings for patients whose clinical need does not require a hospital bed, and for whom a hospital bed is not where they want to be.

It is not a new concept. Every clinician has an instinctive version of it. The Value Forge is an attempt to make it the explicit standard against which every piece of clinical intelligence in this system is measured. Does this help the patient from Hull live better? If not, why are we surfacing it?

This is what thoughtful practitioners do. Every day, to greater and lesser degrees, without calling it anything. The Value Forge is an attempt to do it more deliberately, more consistently, and more honestly than the default.

4. Beyond the Valley

The Value Forge began from a particular geography. Hull and the East Riding were the first frame because they were the place I knew best, the population whose needs I understood most directly, and the system in which the gap between evidence and experience was most visible to me. The origin was local because all honest work begins somewhere.

But the development of The Value Forge has changed the nature of the project.

It is no longer best understood as a Hull and East Riding intelligence product. It is better understood as a method for translating evidence across domains, populations, and systems. Its starting point was local. Its purpose is now wider.

That distinction matters. Place remains relevant, but it is not the boundary of the work. Deprivation, rurality, coastal communities, workforce constraints, access, demography, and culture all shape what good care means in practice. But none of those factors are unique to one locality, and none can be understood properly if the field of learning is kept artificially narrow. Hull may sharpen the question. The East Riding may expose a particular access problem. Scarborough may explain something about origin, memory, and obligation. But the answers must be sought more widely than the places that first made the question urgent.

The Value Forge therefore now looks outward deliberately: to national guidance, international evidence, comparative practice, emerging models, and lessons from systems facing similar problems in different forms. The question is no longer simply, “What does this mean for Hull and the East Riding?” It is, “What can be learned, from anywhere, that improves the way patients experience care?”

That shift carries a cost. A broader publication will sometimes be less locally granular. It will not always describe the precise texture of coastal access, rural isolation, urban deprivation, or the particular constraints of one provider collaborative with the same specificity as a purely local report. That is a real trade-off, not something to conceal. But the gain is also real: a wider base of comparison, a stronger field of learning, and a greater chance of identifying patterns that are not visible from one locality alone.

The aim is not to dilute local relevance. It is to avoid mistaking local origin for local limitation.

Forge Valley remains the place where the work began. It gives the publication its name, its first moral claim, and its sense of obligation. But The Value Forge is not confined to the valley, the city, the county, or the region. It is an attempt to build a way of seeing evidence that can travel: across frailty, psychology, palliative care, therapies, OPAT, and beyond; across localities with different pressures; across systems trying, in different ways, to close the same gap between what is known and what is done.

The work was born from this place. It is not bounded by it.

5. Folding the Steel

The Value Forge runs on a set of routines. Each day, a morning intelligence brief draws on the overnight evidence landscape across the five domains — new publications, updated guidance, emerging signals — and synthesises what matters for this population into a form that can be acted on. Each week, a fuller evidence watch goes deeper: primary literature, systematic reviews, NICE and NHS England publications, cross-referenced against what is already known and flagged for relevance to the Hull and East Riding context. A weekly synthesis and bulletin draws those threads together. Each month, a meta-synthesis applies the full analytical framework — not just summarising what was found, but asking what the pattern of findings means across domains, where convergences are emerging, where contradictions need resolving, what the evidence is collectively pointing at that no single domain synthesis can see alone.

The Monthly publication — this — is where that accumulated synthesis becomes argument.

Describing these routines accurately is necessary. It is not sufficient. The routines are the mechanism. What matters is what the mechanism produces over time, and why that is qualitatively different from what any single cycle can achieve.

Japanese swordsmiths fold the steel repeatedly during the forging process. Each fold doubles the layers. After fifteen folds there are more than thirty thousand layers, and what began as raw material has become something that could not have existed at the start — not merely stronger, but structurally different, the impurities worked out, the grain aligned, the material capable of holding an edge that unfolded steel cannot hold. The folding is not repetition. It is transformation through repetition.

The Value Forge is designed to compound in the same way. The first edition of this Monthly is new steel. It is honest about what it is: a first synthesis, built on a first cycle of evidence watching, without the depth that comes from seeing patterns recur and diverge across multiple cycles. Edition four will be different. Edition twelve, a year from now, will be different again — not because more has been added, but because the synthesis will have the depth to see what is not visible at the start. Which findings persist across cycles. Which apparent convergences dissolve under further scrutiny. Which open questions keep recurring because they are pointing at something the system has not yet been able to name.

The forge remembers. The steel gets stronger.

This is why the open questions section of every edition is not a gesture toward intellectual humility. It is the primary compounding mechanism. The question that recurs unresolved across recurring monthly cycles is more important than any single finding, because it is telling you something the synthesis cannot yet reach.

Edition one cannot be anything other than what it is. That is not a limitation. It is the correct starting position for any enterprise that intends to be honest about what it knows.

6. The Lens

Evidence does not interpret itself. A meta-analysis on hospital at home tells you what the study found. It does not tell you what the finding means for a frail older person living in a dispersed rural East Riding community, or whether the incentive structures in this system would allow the finding to be acted on even if the translation were made. Those questions require a framework — not a checklist applied after the fact, but a set of lenses through which every synthesis is interrogated from the start.

The Value Forge draws on six thinkers as analytical lenses. They are not cited as sources. They are applied as methods — ways of asking the question differently enough that what one lens misses, another finds.

Daniel Schmachtenberger’s contribution is systemic rigour: the insistence on mapping the whole before intervening, tracing generator functions rather than treating symptoms, and holding every proposed solution to the question of whether it addresses the root cause or merely displaces the problem. When a finding suggests an intervention, the prior question is: what is producing the problem the intervention addresses? If frailty discharge delays keep rising despite community investment, the generator function is not insufficient capacity. It is the structural conditions that make acute admission the path of least resistance at every decision point across the pathway.

Iain McGilchrist’s contribution is the corrective to reductive analysis: the insistence that the whole cannot be recovered from its parts, and that the kind of attention brought to a problem determines what it is possible to see in it. In frailty, where the patient is irreducible to their clinical measurements, and in palliative care, where the meaning of the time remaining cannot be captured in a quality-adjusted life year, this corrective is not a philosophical nicety. It is a clinical necessity.

Eric Weinstein’s contribution is the challenge function: the willingness to question institutional consensus, surface what credentialled groupthink has normalised, and ask who benefits from a particular framing being maintained. The diagnostic question here is not what the data shows. It is what you would have to believe to think the current system is performing adequately for this population. The answer is more revealing than any single metric.

John Lennox’s contribution is precision at the limits of knowledge: the discipline of distinguishing what the evidence demonstrates from what it suggests, and what remains genuinely unknown. Every synthesis produced by this system carries that distinction. A finding grounded in a meta-analysis is not the same as a finding grounded in inference or synthesis. The labels matter. Conflating them costs more than acknowledging the uncertainty.

Sherlock Holmes’s contribution is abductive discipline: evidence before theory, systematic elimination, and the willingness to follow the logic wherever it leads even when the conclusion is uncomfortable. The question applied to every finding: given these observations, what is the most parsimonious explanation? What would have to be true for the alternative to be correct?

Lieutenant Commander Data’s contribution is dispassionate transparency: stating what is known, what is unknown, and what is genuinely uncertain, without institutional comfort distorting the account.

These lenses do not always agree. When Schmachtenberger and Holmes converge on the same generator function from different directions, that is a stronger finding than either alone. When McGilchrist identifies what the data has reduced out of view and Lennox flags that the evidence for a claim is weaker than its framing suggests, those become open questions — carried forward, not resolved by assertion. The convergences and divergences are themselves part of the intelligence. Six lenses are not a methodology document. They are a discipline of attention, applied at every synthesis cycle, generating questions as often as answers, and holding the system to the standard of intellectual honesty it was built to maintain.

7. Plan. Do. Study. Act.

There is a discipline familiar to everyone who has worked in NHS improvement that structures what follows. Plan, Do, Study, Act. Most people have encountered it in training. Some have used it well. Some have had it applied to them in ways that reduced it to a compliance exercise with a coloured template. In my experience, more often than not it sits on the shelf of things we know we should do but rarely get round to, because the operational reality of management is rarely structured in a way that makes it routine. There have been exceptions to that rule. I may return to them here if relevant.

Used honestly, it is something simpler and more demanding than the coloured template suggests: an acknowledgment that planning and doing are different things, that the difference matters, and that the willingness to learn from the gap between them is the condition for any genuine improvement.

This editorial is the Plan made legible. It is written before the evidence exists. That is not a weakness — it is the honest position of every worthwhile enterprise at its beginning, and it is the only position from which genuine accountability can be constructed. If the Plan is never stated, the Act can never be assessed against it.

The Plan is this. A weekly evidence watch across five clinical domains, drawing on PubMed, Cochrane, NICE, and NHS England publications, translated from what the literature says to what it means for this population. A daily intelligence brief, synthesising what matters today across the domains. A weekly synthesis and bulletin that begins to build the picture across domains rather than within them. A monthly meta-synthesis that applies the full rigour of a bespoke analytical framework — tracing patterns, identifying convergences, naming contradictions, asking what the evidence is actually pointing at. And this — the Monthly publication, and specifically this editorial — as the place where the argument is made. Where the evidence scan that precedes these words is interpreted, challenged, and held to the question: what does this mean for the way we lead this system?

The Do is not this system. The Do is a frailty nurse making a discharge decision at four in the afternoon, with a patient who is medically optimised but whose home situation is precarious and whose carers have not yet been confirmed. A palliative consultant sitting with a family who have not yet had the advance care planning conversation that would tell everyone — including the patient — what a good death might look like for this person. A community therapist assessing whether functional capacity is sufficient to go home today, or whether one more day of rehabilitation changes a trajectory that, without it, points toward residential care. A general practitioner, perhaps much like the one my grandmother saw, with twelve minutes and a presentation that may or may not connect to something more significant underneath.

Those decisions happen regardless of whether this system exists. They are made every day, across this patch, by people doing their best within the constraints they have. The Value Forge does not make those decisions. It changes — by a degree — the information environment in which they are made. Whether that degree matters is what time and honest reflection will determine.

There are four distinct gaps between evidence-supported care and the care patients in Hull and the East Riding actually receive. The first is epistemic: the relevant actors do not know what the evidence says, or cannot access it in a form they can act on. The second is translation: the evidence is known in general, but the distance between population-average findings and what those findings mean for this specific population has not been crossed. The third is incentive: the relevant actors know what good looks like but the structures surrounding them reward different behaviour — activity over outcome, throughput over value. The fourth is capacity: they know, and want to deliver good care, but lack the workforce, the infrastructure, or the resource to do so.

The Value Forge is designed to close the first two gaps. It is not designed to close the third and fourth. That is a scope definition, not a failure of ambition. A system that claimed to address incentive and capacity problems through better intelligence would be making a false promise, and false promises in healthcare cost more than the problems they claim to solve. The honest account is narrower: this system addresses the epistemic gap across five clinical domains simultaneously, and closes the translation gap for a specific population in a way that no existing regional synthesis infrastructure currently achieves for this place. Those are real contributions. They are not sufficient to resolve everything. They are worth making regardless.

I think of the streams in Forge Valley. The clearing was not a guarantee that the water would reach the Old Man’s Mouth. There were other blockages further down. The river had its own conditions. What the clearing guaranteed was that this particular obstruction was no longer in the way. Sometimes that was enough to change the flow. Sometimes the flow found another problem downstream. The work was worth doing either way, because the alternative — leaving the blockage and walking past it — was not acceptable if you had already seen the water backing up and understood what the waterfall was for.

8. What the Study Phase Will Actually Ask

The easiest thing to do at this point would be to describe how we will measure success. To offer a list of metrics, a set of indicators, a governance framework. There is a governance document. There are metrics. They exist for good reasons.

But the more important question is harder to measure and more consequential to get right. It is not whether this system produces outputs. It is whether this population’s encounter with the health system adds more genuine value to their lives as a result of its existence. The distinction matters because outputs are easy and outcomes are difficult, and the history of NHS improvement is substantially the history of confusing one for the other.

Value added time is the measure we hold ourselves to. Not the frequency of the evidence watch. Not the reach of this publication. Not the engagement in the channels or the quality scores on any individual synthesis. Whether the frail older person from Hull is more likely to have their rehabilitation potential properly assessed before a decision about their care setting is made. Whether the person dying in the East Riding is more likely to have had the advance care planning conversation that lets them die where they wanted to die. Whether the psychological need sitting invisible beside a physical health condition is more likely to be identified and addressed, rather than recorded and deferred until crisis.

Those outcomes are difficult to attribute to any single intelligence system. They are shaped by the full complexity of what a health system does and does not do — by commissioning decisions, workforce capacity, community infrastructure, and the incentive structures that govern how decisions are made at every level. Honest attribution is hard, and anyone who claims it straightforwardly is not being careful enough. What can be done is to watch the direction of travel, note where clinical and operational thinking appears to shift, and ask the question plainly when the evidence warrants it.

If the system runs well and decisions do not improve proportionately, that is important information. It would suggest that the epistemic and translation gaps are not the primary constraints — that the incentive and capacity gaps are more load-bearing than this system’s design acknowledges. That finding, if it emerges, will be reported here. It would not be a failure of the system to acknowledge it. It would be the system working as designed: building in the Study phase from the start, and taking seriously what it finds.

The open questions section of every edition of this Monthly exists for exactly this purpose. Not as a performative gesture toward intellectual humility. As a genuine record of what this system does not yet know, held in view across cycles, flagged when the same question recurs without resolution. Recurring unresolved questions are the most honest signal of where a system is working against itself. They belong in print.

9. The Act and What It Requires

The Act phase of a PDSA cycle is where most improvement work quietly fails. The Plan is thoughtful. The Do happens. The Study produces findings. And then the Act — the genuine change in response to what was learned — is deferred, diluted, or absorbed into the institutional preference for continuity over correction. This is not a failure of individuals. It is the natural behaviour of any system in which acknowledging that the Plan was wrong carries professional cost, and in which the incentive to reframe evidence rather than change course is structural rather than personal.

The commitment made here is therefore specific rather than aspirational. If what the Study phase reveals contradicts what the Plan assumed, this publication will say so. If the translation gap proves less significant than the incentive gap — if better intelligence does not move decisions because the structures around those decisions reward different behaviour — the editorial in the relevant edition will name that plainly. If the population specificity assumption turns out to be less load-bearing than expected, that finding belongs in print, not in a file. If this system is not working, the most honest thing it can do is report that honestly, and either adapt or stop.

This is the standard I am holding this work to. Not because accountability is a management virtue to be performed, but because accountability is what distinguishes genuine improvement from its performance. The system that only publishes its successes is not an intelligence system. It is a communications function.

There are foundational inequalities in the structure of our society that healthcare and social care cannot fix. The distance between the rich and the poor, in health outcomes as in everything else, is not a problem that better clinical intelligence will resolve. What it can do — what it is obliged to do, given the resources it consumes and the responsibility it carries — is to optimise what is within its reach, to be honest about what is not, and to make the gap between the two as visible as possible to those who operate at the levels where structural change is possible.

As a manager within this system, my responsibility is to be accountable for the decisions made — or not made — in my name, and for their consequences. This publication is part of that accountability. Not the whole of it. Part of it.

10. Why the Labour Is Worth It

There is a waterfall in Forge Valley that most people who walk through it probably do not notice. It is not dramatic. It does not appear on tourist maps or earn its way into photographs. It is a small cascade — perhaps two metres — where a stream that has been gathering itself through the oak and ash of the valley finally finds the main river and drops into the larger flow below. The locals call it the Old Man’s Mouth.

My grandmother and I used to clear the path to it. On autumn afternoons, when the fallen leaves had blocked the smaller channels, we would work upstream, removing what had accumulated, restoring the flow. It took hours. The water would have found its way eventually regardless — streams are patient in ways that people rarely manage. But the clearing meant it found its way sooner. It meant less water backing up where it caused damage. It meant the cascade, when it arrived, was stronger.

I named this system after that valley. The Value Forge. Not as a metaphor borrowed for effect, but as an honest account of where the reason for building it came from. She is the reason. The waterfall is the reason. The patient from Hull who keeps going back to her GP because she knows something is wrong, and waits for a referral, and waits for an appointment, and by the time the diagnosis arrives it has become something that cannot be undone — she is the reason. My grandmother did not benefit from better clinical intelligence about breast cancer presentation in women of her age, with her history, in her system. She did not benefit from a translation of national guidance into what it meant for her, in Scarborough, at that point in her illness. I cannot give that back to her.

What I can do is try to make sure the same gap is smaller for the next person navigating this system. Not closed — I have been honest about what this system can and cannot reach. Smaller. The water flowing with less obstruction. The gap between what the evidence supports and what patients receive, in Hull and the East Riding, across five clinical domains, reduced by the degree that better, more deliberately translated intelligence can reduce it.

The work is the evidence. The evidence does not yet exist. That is the true position at the beginning of any enterprise worth beginning.

Be the person who you are on the inside.

One of the last things my grandma said to me was that. I have not always done that. I am sorry.

I hope that here I can bring to the surface the person my grandma saw in me, and in doing so bring something to the community that would honour her and what she believed in with all her heart and soul.

I hope that she would have been pleased.

11. Executive Summary

The Value Forge is a clinical intelligence initiative born from a personal history of loss and a professional determination to reduce the gap between what healthcare systems know and what patients actually experience. Inspired by the author’s grandmother, whose cancer diagnosis was delayed by the cumulative effects of system friction, the project began as an exploration of how evidence could be translated more effectively into practice.

Although rooted in the communities of Hull, the East Riding, and the wider Yorkshire coast, The Value Forge has evolved beyond any single locality. Its focus is not the production of place-specific intelligence alone, but the development of a transferable method for translating evidence into actionable knowledge across health and care systems. The challenges it examines — frailty, access, end-of-life care, rehabilitation, psychological need, antimicrobial stewardship, and the efficient use of finite resources — are not unique to one geography, and the search for solutions is intentionally national and international in scope.

Drawing on five core clinical domains and a set of complementary analytical lenses, the framework seeks to identify the systemic conditions that create unnecessary delay, waste, and avoidable deterioration in patient outcomes. Its central concern is the maximisation of value-added time: time that improves, preserves, or meaningfully supports a person’s health, independence, function, or quality of life.

Structured around continuous cycles of evidence surveillance, synthesis, critical analysis, and reflection, The Value Forge applies a disciplined Plan-Do-Study-Act approach to clinical intelligence itself. It is intended neither as a local newsletter nor as an abstract academic exercise, but as a living mechanism for learning — from anywhere that valuable insight can be found — and bringing that learning to bear wherever it may improve care. In that sense, Forge Valley is its point of origin, not its boundary.